Holen Sie sich die Stockscreener-App
13.52
1.40%
-0.24
Arvinas Inc Aktie (ARVN) Neueste Nachrichten
Arbiter Partners Capital Management LLC Invests $3.86 Million in Arvinas, Inc. $ARVN - MarketBeat
Arvinas Highlights Growing Phase 1 Pipeline, Near-Term Catalysts at TD Cowen Healthcare Conference - Yahoo Finance
ARVN: Multiple phase I programs advance with key data and commercialization milestones ahead - TradingView
ARVN: Multiple phase 1 programs advance with key data updates expected for LRRK2, BCL6, and KRAS - TradingView
Arvinas (NASDAQ:ARVN) Director John Houston Sells 35,297 Shares - MarketBeat
Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials - Insider Monkey
Arvinas (NASDAQ:ARVN) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
TD Cowen Health Care Conference - marketscreener.com
Arvinas Holding Company (ARVN) Gets a Hold from Morgan Stanley - The Globe and Mail
Arvinas, Inc. (ARVN) Stock Analysis: Navigating the 6.50% Upside Potential Amidst Clinical Innovations - DirectorsTalk Interviews
HC Wainwright Estimates Arvinas' Q1 Earnings (NASDAQ:ARVN) - MarketBeat
Arvinas Holding Company (ARVN) Receives a Buy from Wells Fargo - The Globe and Mail
Arvinas outlines 2026 clinical data milestones and maintains cash runway into second half of 2028 amid strategic pipeline focus - MSN
Analysts Conflicted on These Healthcare Names: Akebia Therapeutics (AKBA), Idexx Laboratories (IDXX) and Arvinas Holding Company (ARVN) - The Globe and Mail
New CEO at local biotech firm is leading shift to early-stage drugs - Yale Daily News
Barclays Reaffirms Their Buy Rating on Arvinas Holding Company (ARVN) - The Globe and Mail
Arvinas CSO Cacace sells $43,885 in stock to cover tax obligations - Investing.com Australia
Arvinas chief accounting officer Loomis sells $13k in stock By Investing.com - Investing.com South Africa
Teel Randy, president and CEO of Arvinas, sells $58k in stock By Investing.com - Investing.com Australia
Teel Randy, president and CEO of Arvinas, sells $58k in stock - Investing.com Canada
Arvinas chief accounting officer Loomis sells $13k in stock - Investing.com Australia
Arvinas (NASDAQ:ARVN) CAO David Loomis Sells 1,108 Shares - MarketBeat
Arvinas (NASDAQ:ARVN) CEO Randy Teel Sells 4,786 Shares - MarketBeat
[Form 4] ARVINAS, INC. Insider Trading Activity - Stock Titan
5 Analysts Assess Arvinas: What You Need To Know - Benzinga
Arvinas (NASDAQ:ARVN) Trading Up 9%Still a Buy? - MarketBeat
Arvinas (NASDAQ:ARVN) Receives Overweight Rating from Piper Sandler - MarketBeat
Piper Sandler Raises Price Target on Arvinas (ARVN) to $20.00 | - GuruFocus
ARVN: Evercore ISI Raises Price Target to $19, Maintains Outperf - GuruFocus
Arvinas (ARVN): Wedbush Maintains Neutral Rating and Raises Pric - GuruFocus
Arvinas, Inc. (NASDAQ:ARVN) Q4 2025 Earnings Call Transcript - Insider Monkey
Arvinas (ARVN) Q4 Loss Of US$67.4 Million Reinforces Profitability Concerns - Sahm
Arvinas earnings missed by $0.59, revenue fell short of estimates - Investing.com Australia
Arvinas, Inc. (NASDAQ:ARVN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Arvinas (ARVN) Reports Significant Revenue Decline in Q4 - GuruFocus
Wedbush raises Arvinas stock price target to $11 on pipeline progress By Investing.com - Investing.com South Africa
Wedbush Maintains Neutral on Arvinas, Inc. (ARVN) Feb 24, 2026 - Meyka
ARVINAS, INC. SEC 10-K Report - TradingView
Wedbush raises Arvinas stock price target to $11 on pipeline progress - Investing.com Australia
Arvinas Inc (ARVN) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges with ... By GuruFocus - Investing.com Canada
Arvinas (ARVN) Projects Financial Stability into Late 2028 - GuruFocus
Arvinas Inc (ARVN) Q4 2025 Earnings Call Highlights: Navigating - GuruFocus
Wedbush Lifts Price Target on Arvinas to $11 From $9, Keeps Neutral Rating - marketscreener.com
Arvinas (ARVN) Q4 2025 Earnings Call Transcript - AOL.com
Arvinas Q4 2025 Earnings Call Transcript - MarketBeat
Arvinas, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
ARVN: Strong cash position and pipeline progress set up multiple clinical milestones for 2026 - TradingView
Arvinas Q4 Earnings Call Highlights - MarketBeat
Arvinas (NASDAQ:ARVN) Shares Gap Down After Earnings Miss - MarketBeat
Earnings call transcript: Arvinas Inc. Q4 2025 results miss expectations, stock dips - Investing.com Nigeria
Arvinas (NASDAQ:ARVN) Releases Earnings Results, Misses Expectations By $0.55 EPS - MarketBeat
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
4.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):